Trending...
- Hiclean Tools Releases HCX2100 Electric Pressure Washer
- DALPS Launches Marketplace Allowing Businesses to Trade Offers Like Stocks
- Some Music for Donald's Bad Day
LOS ANGELES--(BUSINESS WIRE)--Respira Technologies, Inc.—a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases—has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira's founder, Mario Danek, will transition to the role of Chief Technology Officer.
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Quigley spent 16 years at Altria Group, with seven years as President & CEO at Altria's Smokeless and Innovative Products/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.
With Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company's leadership team. Quigley's background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.
More on The Californer
- California expands CalAssist Mortgage Fund Disaster Relief: More California families to qualify for mortgage grants
- NBA Overachievers: OddsTrader Reveals Which Teams Will Exceed Expectations in 2025-26
- Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
- The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague
- DJ Expert Warns Couples: "Bargain Wedding DJs Are Backing Out for Higher-Paying Gigs Leaving Clients Scrambling"
Respira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.
About Respira Technologies, Inc.
Respira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.
The company's key product, the RespiRx™, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx™ can deliver.
Respira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.
Contacts
Investor Relations:
Respira Technologies, Inc.
IR@Respiratechnologies.com
Media Relations:
Richard Laermer
RLM PR
212-741-5106 X 216
Respira@RLMpr.com
Filed Under: Business
0 Comments
Latest on The Californer
- ZapperBox NextGen TV Gateway Receiver Now Testing Support For Secure Whole-Home Content Distribution
- Life as a Dog: P-Wave Press Brings Readers a Heartwarming Memoir of Love, Laughter and Companionship
- NOYA Launches Premium, Design-Forward Training Gear That Belongs at the Center of Your Space
- Tanbii Raises $3 Million to Launch Web3 Game Lets You Plant Virtual Trees and See Real Trees Grow
- Clear Winner Offers $100 Off New Window Installations in Palm Desert, CA
- 2 Pianos 4 Hands at North Coast Repertory Theatre
- Eisenhower: This Piece of Ground at North Coast Repertory Theatre
- Research Defense Examines Violence, Illiteracy, Non-Active Fathers, and Low Self-Esteem Among Males
- Investing in Greece: Your Definitive Real-Estate FAQ Guide
- California: Governor Newsom announces appointments
- California: TOMORROW: Governor Newsom to discuss the economic advancement and growth of the state
- California: Governor Newsom to Trump: We're suing immediately if you send troops into San Francisco
- Long Beach: City to Host Neighborhood Halloween Carnival at Silverado Park
- Altadena Mountain Rescue Team Recognized with 2025 ReadyCommunities Partnership National Service Award For Determination and Resilience
- Long Beach to Host Urban Forest Plan Kickoff Meeting
- Alander Lee Pulliam Jr. Declares His Bold Rise in Politics: A Mission Rooted in Service and Justice
- Alander Pulliam Unveils "Platform for Transformation" – A Bold Blueprint to Dismantle Oppres
- KeysCaribbean Offers 20 Percent Off Seven-Night Stays For Private Home Collection Properties
- Advancing Circular Economy in Automotive ESD Packaging
- Playwrights Announced For The 2025 Bill And Judy Garrett Finish Line Commission